| Literature DB >> 27718171 |
Nalani Haviland1, John Walsh1, Ruth Roberts2, Timothy S Bailey3.
Abstract
Since the early 2000s, continuous glucose monitoring (CGM) technology has advanced to become a standard of care in the treatment of type 1 diabetes. Unfortunately, CGM use is not commonly integrated into practice. This article will review the history, technology, and need for systematic training in CGM. Additionally, it will review recent clinical trial data demonstrating the benefits that CGM offers to all people with type 1 diabetes and the clinicians who care for them.Entities:
Keywords: Artificial pancreas; CGM; Continuous glucose monitoring; Insulin therapy; Type 1 diabetes
Mesh:
Substances:
Year: 2016 PMID: 27718171 DOI: 10.1007/s11892-016-0808-5
Source DB: PubMed Journal: Curr Diab Rep ISSN: 1534-4827 Impact factor: 4.810